Tvardi Therapeutics, Inc.

TVRD·NASDAQ·$3.44Share Price as of 11/2·$32MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/08/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report08/14/26 8-KCurrent report07/30/26 8-KCurrent report07/17/26 8-KCurrent report07/07/26 8-KCurrent report06/11/26

Prospectuses and Registrations

424B5Prospectus supplement07/17/26 POS AMPost-effective amendment05/08/26 S-3Shelf registration05/01/26 424B3Prospectus04/01/26 POS EXPost-effective amendment (exhibits)04/01/26

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26 DEF 14ADefinitive proxy04/22/24 DEFA14AAdditional proxy materials04/22/24 PRE 14APreliminary proxy04/12/24

Ownership

Form 4Insider transaction06/11/26 Form 4Insider transaction06/11/26 Form 4Insider transaction06/11/26 Form 4Insider transaction06/11/26 Form 4Insider transaction06/11/26

Other

EFFECTRequest for effectiveness05/13/26 EFFECTRequest for effectiveness05/12/26 CORRESPCorrespondence with the SEC05/08/26 UPLOADLetter from the SEC05/07/26 ARSAnnual report to shareholders04/23/26